Pegylated recombinant human leptin
Alternative Names: PEG-OB; Pegylated recombinant native human leptinLatest Information Update: 05 Jul 2006
At a glance
- Originator Roche
- Class Obesity therapies; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 05 Jul 2006 No development reported - Clinical-Phase-Unknown for Obesity in USA (SC)
- 15 Mar 2001 Investigation in Obesity in USA (SC)